Team of Experts Develop Nasal Spray Against COVID-19 VirusAugust 19, 2020
The University of California at San Francisco successfully developed a nasal spray with one of the most potent SARS-CoV-2 antivirals yet discovered. Known as AeroNabs, it is promising protection against the COVID-19 virus until a vaccine becomes available. The performance of the antiviral is published in bioRxiv.
The inventors describe AeroNabs as a molecular form of personal protective equipment (PPE), which is far more effective than wearable forms of PPE such as masks and suits. The team of developers is composed of experts from the fields of biochemistry, cell biology, virology, and structural biology. The development of AeroNabs is inspired by nanobodies or the antibody-like immune proteins that are naturally present in llamas, camels, and related animals. According to the researchers, nanobodies are similar to antibodies in the human immune system but are smaller and has unique characteristics making them effective therapeutics against SARS-CoV-2. For instance, the small size of nanobodies makes it easier to manipulate and modify in the laboratory. The small size also makes them more stable than other antibodies in the mammalian immune system. Nanobodies can be easily mass-produced using inexpensive methods such as inserting the genes that carry the molecular blueprints to build nanobodies into microbes, then the microbes will serve as high-output nanobody factories. This technique has been successfully employed in the production of insulin for decades.
The inventors are in discussions with commercial partners to proceed with manufacturing and clinical testing of AeroNabs.
You might also like:
- Study: Heartburn Medicine Doesn't Work as COVID-19 Antiviral
- The Role of Plant Biotechnology Against SARS-CoV-2
- CRISPR Technique 90% Effective in Reducing SARS-CoV-2 Coronavirus
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Evidence Shows GM Foods Do Not Cause Infertility
- Scientists Decode Complete Sequence of Human Chromosome X for the First Time
- Groups Push for Bt Brinjal Field Trials in India
- Europeans Now Less Skeptic About GMOs
- Wheat Gene Confers Stem Rust Resistance to Barley
- New Biofortification Method Transforms Leaves into Nutrient Stores
- Study Shows Fate of Multiple Bt Proteins from Bt Maize in the Predatory Lady Beetle
- CRISPR-Cas RNA Targeting Using Transient Cas13a Expression in Nicotiana benthamiana
- Yield10's CRISPR Genome-Edited C3007 Canola Trait in 2021 US Field Tests
- Researchers Discover Vulnerability in SARS-CoV-2
- Q&A: COVID-19 Pandemic's Impact on Food and Agriculture
- Team of Experts Develop Nasal Spray Against COVID-19 Virus
Read the latest:
- Biotech Updates (February 1, 2023)
- Genome Editing Supplement (January 18, 2023)
- Gene Drive Supplement (January 25, 2023)
Subscribe to BU: